Thierry Boon
Thierry Boon is a
Université Catholique de Louvain. He observed that tumour cells that have acquired new mutations as a result of mutagen treatment in vitro, often become incapable of forming tumours because they express new antigens recognized by the T cells of the immune system. His research allowed him to isolate the genes that code for these so-called tumour antigens.[1]
He is a member of the Cancer Research Institute Scientific Advisory Council, The National Academy of Sciences, and The Academy of Cancer Immunology.
Awards
- 1986: Rik & Nel Wouters Prize
- 1986: De Vooght Prize in Immunology
- 1987: Cancer Research Institute William B. Coley Award
- 1990: Dr. Josef Steiner Cancer Research Prize
- 1990: Francqui Prize on Biological and Medical Sciences
- 1994: Louis-Jeantet Prize for Medicine[2]
- 1994: Rabbi Shai Shacknai Memorial Prize in Immunology & Cancer Research
- 1995: Sandoz Prize in Immunology
- 1999: Leopold Griffuel Prize
References
- ^ Boon T, Kellermann O., Rejection by syngeneic mice of cell variants obtained by mutagenesis of a malignant teratocarcinoma cell line, Proc Natl Acad Sci U S A. 1977 Jan;74(1):272–5
- ^ Louis-Jeantet Prize
External links
- Ludwig Cancer Research
- Group of Thierry Boon @ LICR Brussels
- Admission to NAS
- Stepping down as Branch Director of LICR Brussels
- Francqui Foundation
- Louis Jeantet Prize
- Académie royale de Belgique
- Interview with Thierry Boon - Sciencewatch
- Lexpress.fr
.svg){kind=small}   | This article about a Belgian scientist is a stub. You can help Wikipedia by expanding it. |